Navigation Links
Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
Date:10/15/2007

FI) funded research centre headquartered in University College Cork (UCC), with scientists and clinicians also based in Teagasc Moorepark, Cork University Hospital and Alimentary Health Ltd. The APC is investigating mechanisms by which intestinal bacteria influence health and disease and is developing new therapies for lifelong debilitating gastrointestinal diseases such as gastroenteritis, ulcerative colitis and Crohn's disease. For information please visit http://apc.ucc.ie/.

About Align

Align is a daily probiotic supplement that helps build and maintain a strong and healthy digestive system.* Align works by providing a natural defense against episodic digestive upsets such as constipation, diarrhea, abdominal discomfort, urgency, gas and bloating. Align is the only probiotic supplement containing Bifantis (Bifidobacterium infantis 35624). Please visit AlignGI.com for more information.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Contacts:

Bob Mathias Barry Kiely Shirley Johnson

Alimentary Health Alimentary Health Manning, Selvage & Lee

Phone 1 480 248 7278 +353 21 429 9104 (212) 468-3292

Email bmathias@ahealth.ie bkiely@ahealth.ie shirley.johnson@mslpr.com


'/>"/>
SOURCE Alimentary Health
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
3. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
4. Medicures MEND-CABG Trial Results Published in Peer Reviewed Journal
5. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
6. Salix Pharmaceuticals Previews Digestive Disease Week 2007
7. Reatas Synthetic Triterpenoids Profiled in Nature Reviews Cancer
8. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
9. Isotechnikas independent data monitoring committee conducts review of phase 2b kidney transplant trial
10. Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
11. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2009)...6 The Michael J. Fox Fo...four industry research teams for pre-clinical rese...isease. , , The funding was awarded under the F... This program, first launched in 2006, supports an... research. TDI is part of MJFF,s focus on ,de-...
(Date:1/5/2009)... 5 Cylene Pharmaceuticals announce...rial of its oral CK2 protein kinase inhibitor, CX-...leman,s disease, or multiple myeloma. The primary ...termination of safety, tolerance and PK properties... Phase II trials. In addition, multiple mechanism-...
(Date:12/29/2008)...Dec. 29 The winner of t...tection was announced today by Dr. Peter G. Goldsc...ment Institute. , , The winner of the annual a... Cancer Center -- for its best practice " IND Re...ovides for 1) enhanced human subjects protection, ...
(Date:12/17/2008)... show for the first time that normal stem cells ca...ues , , MEMPHIS, Tenn., Dec. 17 /PRNewswire...s Research Hospital have answered a central questi...n give rise to tumors. Stem cells are immature cel...re differentiated cells that compose the range of ...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 32008 Human Research Protection Award Recipients Announced 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 33 D photonic crystals will revolutionize telecommunications 1888 13 D photonic crystals will revolutionize telecommunications 1888 23 D photonic crystals will revolutionize telecommunications 1888 3Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 6757 1Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 6757 2Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 6757 3MEDRAD Mobile MR Injector Meets Challenges of MR Trailers 6755 1MEDRAD Mobile MR Injector Meets Challenges of MR Trailers 6755 2Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 1Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 2Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 3Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 4Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 5Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 6Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 7Franklin 26 Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6753 8
(Date:1/8/2009)...ber Tom Torlakson Introduces AB 89 , , SACRAMEN...day, Lung Cancer Alliance-California (LCA-CA), hai...th District) for his continued leadership in intro...er research. For the third consecutive year, legi...ing considered in the California Legislature. ,...
(Date:1/8/2009)...dy could shape new treatments for secondary pneumo...wswire/ -- Scientists at St. Jude Children,s Resea...eatment for bacterial pneumonia following influenz... azithromycin, which kill bacteria by inhibiting t...standard first-line treatment with the "beta-lacta...
(Date:1/8/2009)...n hurtful comments, study suggests , , ...verestimate how strongly they would react to racis...ee percent of study participants at York Universit...iment with a white person rather than a black one,...about the black person when he left the room. ,...
(Date:1/8/2009)...ildren,s Research Hospital have demonstrated a mor...owing influenza. They found that the antibiotics c...y inhibiting their protein synthesis, are more eff...he "beta-lactam" antibiotic ampicillin, which caus...ng is important because pneumonia, rather than the...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Many Turn Blind Eye to Racism 2Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3
... had reported that the blood samples of autistic c...nents of the immunity system. This may be the firs... the blood tests of children. Autism spectrum diso... seen in a mild to the most sever form. The charac...
...hers say cholesterol may be actually needed to hel...ever researchers also say that too much of it coul...eries, where it builds up as plaque and can cause ...uggest an enzyme called ACAT2 may be to blame for ...
...regnancy not only decides the health// of the fetu...n as well. In a study to understand fetal developm...und out about long-term influence on the genetic c...ealth of the next few generations. Their research ...
... UK, has provided new guidelines //for dealing wit...uidelines suggest that psychological therapy be gi...ral or man made is always tough. NICE had emphasiz...thing shelter to these traumatized people it is al...
Other Medicine News:
Vannas Capsulotomy scissors angled
Gills-Vannas straight capsulotomy flat handle scissors
Vannas angled capsulotomy round handle scissors
Solid blade speculum designed for both temporal and superior approach ocular surgery. Adjustable with thumb screw. Manufactured in titanium.
Medicine Products: